Five years' experience with thalidomide treatment in leprosy reaction.
D002986:Clinical Trials as Topic; D003248:Constipation / Q000139:chemically induced; D004487:Edema / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000503:physiopathology; D009431:Neural Conduction / Q000187:drug effects; D009443:Neuritis / Q000517:prevention & control; D010919:Placebos; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014459:Ulnar Nerve / Q000503:physiopathology; D014606:Uveitis, Anterior / Q000517:prevention & control; D014717:Vertigo / Q000139:chemically induced
D010919:Placebos; D013792:Thalidomide